Premal Patel, Chief Medical Officer at Elephas, shared a post on LinkedIn:
“I’m excited to join the talented team at Elephas Biosciences, advancing a technology that uses patients’ own live tumor cells to generate clinically actionable insights and help identify the most effective therapies for metastatic cancer—where patients often face limited life expectancy and every treatment decision truly matters. I’m excited by the potential of this technology to substantially advance patient care!
Find out more.”
More posts on OncoDaily.